IP Library Granted Patent US 10,493,011
Granted Patent B2
US 10,493,011 · App. 16/053,674 · Granted Dec 3, 2019

Peptide compositions and methods for ameliorating skin laxity and body contour

Inventors: Alan David Widgerow (Irvine, CA); John A. Garruto (Encinitas, CA)
Assignee: Alastin Skincare, Inc.
A61K8/64A61Q19/00A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,493,011
App. No.
16/053,674
Granted
Dec 3, 2019
Kind
B2
Abstract

Compositions and methods for amelioration of skin laxity and body contour are provided. Provided herein are compositions comprising a combination of peptides.

Claims (19)

1. A topical composition for improving skin laxity, texture or crepiness, or for improving body contouring, comprising:

a tripeptide-1 present at 1-10 ppm,

a hexapeptide-11 present at about 0.001% to about 6% by weight, and

a hexapeptide-12 present at 0.5-10 ppm,

wherein the topical composition improves skin laxity or body contouring.

2. The topical composition of claim 1 , further comprising a tetrapeptide.

3. The topical composition of claim 2 , wherein the tetrapeptide is tetrapeptide-2.

4. The topical composition of claim 2 , wherein the tetrapeptide is present at 1-10 ppm.

5. The topical composition of claim 1 , further comprising ceramide NP, Tremella fuciformis extract, niacinamide, hydrogenated lecithin, C12-16 alcohols, palmitic acid, avocado extract, shea butter, bentonite, phytoene/phytofluene, hydroxymethoxyphenyl decanone, polyholosides, Plantago lanceolata , dill extract, phosphatidylserine, oleuropein, hydrolyzed Candida saitoana extract, Centella asiatica , propanediol, lecithin, Euglena gracilis extract, aqua, caffeine, Glaucium flavum leaf extract, or combinations thereof.

6. A method for improving skin laxity, texture or crepiness, or for improving body contouring, comprising administering the topical composition of claim 1 , wherein the topical composition improves skin laxity or body contouring.

7. The method of claim 6 , wherein the topical composition is administered in conjunction with a body-shaping procedure or following a body-shaping procedure.

8. The method of claim 6 , wherein the topical composition is administered up to one day following a body-shaping procedure.

9. The method of claim 8 , wherein the body-shaping procedure comprises high frequency focused ultrasound, pulsed focus ultrasound, cryolipolysis, radiofrequency induced electroporation, injectable lipolytic agents, liposuction, or combinations thereof.

10. The method of claim 6 , wherein the topical composition is administered one, two, three, four, five, or six times a day.

11. The method of claim 6 , wherein the topical composition is administered for at least one week, 2 weeks, 4 weeks, 8 weeks, or 12 weeks.

12. The method of claim 7 , wherein the body-shaping procedure is an invasive procedure.

13. The method of claim 7 , wherein the topical composition aids in eliminating post-surgical fat fragmentation and its effects.

14. The topical composition of claim 1 , wherein the hexapeptide-11 is present at about 0.002% to about 4% by weight.

15. The topical composition of claim 14 , wherein the hexapeptide-11 is present at about 0.005% to about 0.02% by weight.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2019
From: GARRUTO, JOHN A.; WIDGEROW, ALAN DAVID
To: ALASTIN SKINCARE, INC.
Reel/Frame 048251/0416 →
Continuity (4)
Provisional Application 62696256 · Jul 10, 2018
Provisional Application 62541036 · Aug 3, 2017
Provisional Application 62541022 · Aug 3, 2017
Related Publication 20190038539A1 · Feb 7, 2019
Cited By (2)
US 12,214,009 US 12,357,671